The investigators will assess the usability and immune response following fractional dose
inactivated polio virus vaccine (fIPV) administration with two novel intradermal adapters (ID
adapter by West Pharmaceutical services Inc. and Star Intradermal syringe by Star Syringe
Ltd.) and compare the response with the one achieved with fIPV administered with traditional
BCG needle syringe.